It's turned out to be academic.
The Washington Post, New York Times and Boston Globe have all decided NOT to run the story.
While one view would be the evil hand of Big Pharma suppressed the story it's probably a bit more pragmatic.
If we had FAILED that would have been news, but given the lack of failure....
The problem is that the story was effectively communicated as "Cheaper versions of already proven American drugs have been proven to work by people who are not Americans, treating people who not Americans, reporting to people who are not Americans somewhere which is not in America called Spain, at some conference which is not American called the EASL ILC 2016"
Getting this story to float in the mainstream media in the USA is going to take work, and quite possibly a blonde hair, big boobs and uber fame celebrity endorsement.
Sad as it may be if Pamela Anderson had said "I had Hep C, took generics, and got cured" then the US media would be all over it.